Deerfield Management Company »

National Vision Hldgs shares owned by Deerfield Management Company

Quarter-by-quarter ownership of National Vision Hldgs (EYE) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in National Vision Hldgs

Tip: Access up to 7 years of quarterly data

All positions including National Vision Hldgs held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in National Vision Hldgs by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $266k 10k 25.82
2024-09-30 $983k 90k 10.91

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Brookdale Sr Living Note 3.500%10/1 (Principal)
Cogent Biosciences (COGT)
Praxis Precision Medicines I Com New (PRAX)
Centene Corporation (CNC)
Viatris (VTRS)
Revolution Medicines (RVMD)
United Therapeutics Corporation (UTHR)
Vera Therapeutics Cl A (VERA)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Celcuity (CELC)
Neurocrine Biosciences (NBIX)
Ionis Pharmaceuticals (IONS)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Inspire Med Sys (INSP)

View all positions for Deerfield Management Company

Top funds holding National Vision Hldgs

BlackRock
Vanguard Group
Wellington Management Company
William Blair Investment Management
American Century Companies
State Street Corporation
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
Driehaus Capital Management
Geode Capital Management
FMR
Emerald Advisers
Robeco Investment Management
Fiera Capital Corporation
Charles Schwab Investment Management

View all funds holding National Vision Hldgs